Suzhou Industrial Park Heshun Electric
300141
Guangdong Xiongsu Technology Group
300599
Sichuan Chuanhuan Technology
300547
Shanghai Wisdom Information Technology
301315
KANGNONG SEED
837403
CN Stock MarketDetailed Quotes
300765 CSPC Innovation Pharmaceutical
- 27.55
- +0.14+0.51%
Market Closed Dec 27 15:00 CST
38.70BMarket Cap75.48P/E (TTM)
28.15High27.27Low49.46KlotVolume27.40Open27.41Pre Close137.50MTurnover0.40%Turnover Ratio51.21P/E (Static)1.40BShares37.0852wk High10.15P/B34.36BFloat Cap19.4352wk Low32.89Limit Up1.25BShs Float40.36Historical High21.93Limit Down3.21%Amplitude4.52Historical Low0.27Dividend TTM27.80Avg Price24.87KlotAsk0.97%Div YieldTTM100Lot Size22.34KlotBid
CSPC Innovation Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -59.15%1.29B | -48.90%1.48B | -4.04%2.69B | 71.71%3.77B | 96.62%3.17B | 98.07%2.9B | 64.56%2.8B | 76.44%2.2B | 19.45%1.61B | 15.70%1.46B |
| Transactional financial assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -3.49%301.28M | -6.69%300.78M |
| Notes receivable and accounts receivable | 12.20%513.31M | -11.71%483.24M | -3.63%529.44M | -22.95%464.34M | -7.72%457.47M | 21.07%547.32M | 44.56%549.39M | 42.58%602.68M | 69.13%495.76M | 49.35%452.07M |
| -Notes receivable | 24.20%79.93M | -9.85%86.34M | -43.46%62.38M | -40.67%71.96M | -11.34%64.36M | 37.85%95.78M | 76.23%110.33M | 26.51%121.3M | -15.63%72.59M | -23.92%69.48M |
| -Accounts receivable | 10.24%433.37M | -12.10%396.89M | 6.38%467.06M | -18.49%392.38M | -7.10%393.12M | 18.02%451.54M | 38.31%439.06M | 47.30%481.38M | 104.34%423.17M | 81.00%382.59M |
| Other receivables (including interest and dividends) | 31.99%4.98M | -23.36%2.5M | -31.06%1.91M | -1.03%1.55M | 66.59%3.77M | 132.21%3.26M | 19.50%2.77M | 13.75%1.56M | 1.70%2.27M | -29.04%1.4M |
| -Other receivable | ---- | -23.36%2.5M | ---- | ---- | ---- | 132.21%3.26M | ---- | 13.75%1.56M | ---- | -29.04%1.4M |
| Contractual assets | --11.25M | --11.25M | --11.87M | --11.87M | ---- | ---- | ---- | ---- | ---- | ---- |
| Advance payment | 193.52%73.53M | 92.60%43.41M | 46.10%49.87M | 91.79%37.55M | -42.90%25.05M | 7.53%22.54M | 74.37%34.13M | 10.54%19.58M | 123.42%43.87M | 68.84%20.96M |
| Inventories | 26.93%321.24M | 34.38%300.9M | 14.37%262.04M | -5.59%224.82M | 21.14%253.08M | 6.14%223.91M | -12.45%229.12M | -9.11%238.13M | 20.22%208.9M | 40.89%210.97M |
| Receivable financing | -44.93%49.35M | -63.06%62.15M | -67.79%55.58M | -25.87%84.56M | 65.13%89.62M | 172.55%168.25M | 200.58%172.53M | 32.26%114.07M | 5.88%54.27M | -5.97%61.73M |
| Other current assets | 1,122.61%86.88M | 212.52%53.17M | 67.51%23.16M | 20.38%22.74M | -46.68%7.11M | -27.84%17.01M | -38.90%13.83M | -51.82%18.89M | -39.45%13.33M | -5.20%23.58M |
| Total current assets | -41.18%2.35B | -37.19%2.44B | -4.76%3.62B | 44.73%4.62B | 46.61%4B | 53.11%3.88B | 55.49%3.8B | 28.28%3.19B | 22.85%2.73B | 18.21%2.54B |
| Non Current assets | ||||||||||
| Long-term equity investment | 3.49%264.22M | 3.47%263.28M | 3.83%262.46M | 5.36%267.07M | 4.62%255.3M | 4.69%254.44M | 4.27%252.78M | 4.24%253.49M | 3.60%244.02M | 2.96%243.04M |
| Fixed assets | ---- | 115.97%2.05B | ---- | ---- | ---- | 107.45%947.4M | ---- | 56.04%984.02M | ---- | -4.54%456.68M |
| Fixed assets liquidation | ---- | ---- | ---- | ---- | ---- | --787.21K | ---- | ---- | ---- | ---- |
| Constru in process | ---- | 237.31%355.6M | ---- | ---- | ---- | -36.10%105.42M | ---- | -76.02%70.74M | ---- | 25.91%164.98M |
| Intangible assets | 366.46%226.81M | 363.91%228.4M | 361.64%229.99M | 359.33%231.59M | 19.06%48.62M | 19.03%49.23M | 18.94%49.82M | -4.53%50.42M | -4.06%40.84M | -3.97%41.36M |
| Deferred tax assets | 5.40%17.59M | -12.68%17M | -4.42%17.17M | -8.04%17.36M | -3.43%16.69M | 29.81%19.47M | 4.18%17.97M | 51.04%18.88M | 67.64%17.28M | 34.74%15M |
| Usufruct assets | -44.40%1.01M | -39.95%1.21M | --1.41M | --1.61M | 781.08%1.81M | 389.49%2.01M | ---- | ---- | -80.00%205.79K | -66.67%411.58K |
| Other non current assets | 4,041.79%383.41M | 3,276.90%535.51M | 69.38%20.29M | 65.57%26.33M | -49.92%9.26M | 4.46%15.86M | -15.70%11.98M | -16.56%15.9M | 74.42%18.48M | 56.87%15.18M |
| Total non current assets | 143.55%3.36B | 147.17%3.45B | 106.57%2.84B | 104.86%2.85B | 46.91%1.38B | 48.89%1.39B | 52.33%1.38B | 11.12%1.39B | 3.86%940.3M | 2.47%936.66M |
| Total assets | 6.22%5.72B | 11.54%5.89B | 24.83%6.47B | 63.01%7.47B | 46.68%5.38B | 51.97%5.28B | 54.63%5.18B | 22.53%4.58B | 17.35%3.67B | 13.50%3.47B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Notes payable and accounts payable | 394.99%409.95M | 126.07%311.07M | 171.00%392.97M | 607.37%1.26B | 24.51%82.82M | 197.61%137.6M | 143.64%145.01M | 38.39%178.75M | 0.51%66.51M | -25.74%46.23M |
| -Notes payable | --77.77M | --63.78M | --27.11M | ---- | ---- | ---- | ---- | --20M | ---- | ---- |
| -Accounts payable | 301.09%332.17M | 79.72%247.29M | 152.31%365.86M | 696.48%1.26B | 24.51%82.82M | 197.61%137.6M | 143.64%145.01M | 22.90%158.75M | 0.51%66.51M | -25.74%46.23M |
| Contract liabilities | 9.42%22.95M | -12.33%20.94M | -66.02%14.96M | -70.99%19.8M | -13.46%20.97M | 7.11%23.88M | 149.91%44.03M | 124.79%68.26M | 171.43%24.23M | 224.46%22.3M |
| Salaries payable | -14.27%25.71M | -4.99%27.04M | 17.71%30.24M | 7.74%34.29M | 67.78%29.99M | 98.98%28.46M | 79.90%25.69M | 19.32%31.83M | 41.25%17.88M | 17.57%14.3M |
| Taxs payable | -34.89%19.87M | -58.75%14.93M | -25.85%24.11M | -18.02%32.34M | -10.10%30.52M | 9.86%36.21M | 3.58%32.51M | 120.40%39.45M | 96.31%33.95M | 63.17%32.96M |
| Other payable (including interest and dividends) | 51.75%393.07M | 97.60%500.41M | 78.64%460.91M | 113.69%550M | 70.90%259.02M | 78.66%253.24M | 111.51%258.01M | 27.63%257.39M | 51.76%151.57M | 22.90%141.74M |
| -Other payable | ---- | 97.60%500.41M | ---- | ---- | ---- | 78.66%253.24M | ---- | 27.63%257.39M | ---- | 22.90%141.74M |
| Non current liabilities due within one year | 4.47%832.27K | -18.34%823.42K | 265.96%814.66K | 262.06%806K | 272.87%796.69K | 137.23%1.01M | -64.89%222.61K | -73.53%222.61K | -73.75%213.66K | -48.35%425.03K |
| Other current liabilities | 20.67%2.7M | -5.99%1.64M | -64.74%1.52M | -67.12%2.26M | 13.34%2.24M | 19.66%1.75M | 374.11%4.3M | 238.20%6.87M | 164.84%1.97M | 112.00%1.46M |
| Total current liabilities | 105.25%875.08M | 81.86%876.86M | 81.56%925.52M | 226.70%1.9B | 43.88%426.35M | 85.86%482.15M | 106.95%509.76M | 42.61%582.77M | 43.51%296.32M | 18.82%259.42M |
| Current liabilities | ||||||||||
| Long term loan | ---- | ---- | ---- | ---- | ---- | --19.7M | --19.7M | --19.8M | ---- | ---- |
| Deferred tax liabilities | 973.63%500.22K | -51.36%25.63K | -62.58%24.29K | -62.58%24.29K | -83.71%46.59K | -74.60%52.7K | -88.50%64.91K | -90.33%64.91K | -52.57%286K | -59.80%207.45K |
| Long term deferred income | 155.19%94.4M | 151.03%91.04M | 70.53%63.16M | 126.18%84.16M | 21.25%36.99M | 16.58%36.26M | 16.49%37.04M | 8.59%37.21M | -3.50%30.51M | -3.16%31.11M |
| Lease liabilities | -79.56%213.69K | -65.94%425.11K | --634.27K | --841.22K | --1.05M | --1.25M | ---- | ---- | ---- | ---- |
| Total non current liabilities | 149.74%95.12M | 59.76%91.49M | 12.36%63.82M | 48.97%85.02M | 23.67%38.09M | 82.87%57.27M | 75.54%56.8M | 63.37%57.07M | -5.10%30.8M | -5.29%31.31M |
| Total liabilities | 108.90%970.19M | 79.52%968.34M | 74.62%989.34M | 210.85%1.99B | 41.98%464.44M | 85.54%539.41M | 103.30%566.57M | 44.25%639.84M | 36.90%327.12M | 15.65%290.73M |
| Shareholders equity | ||||||||||
| Paid-in capital | 19.97%1.4B | 19.97%1.4B | 80.00%1.17B | 89.16%1.17B | 114.42%1.17B | 114.42%1.17B | 19.12%650.41M | 13.36%618.93M | 0.00%546M | 0.00%546M |
| Capital reserve funds | -13.64%975.5M | -9.24%975.5M | -24.54%1.2B | 86.63%2.12B | 49.36%1.13B | 42.12%1.07B | 110.93%1.6B | -6.03%1.14B | 0.00%756.28M | 0.00%756.28M |
| Surplus reserve funds | 15.11%329.08M | 25.46%321.79M | 27.47%282.89M | 27.47%282.89M | 81.69%285.88M | 39.73%256.49M | 41.04%221.93M | 41.04%221.93M | 2.41%157.35M | 19.46%183.56M |
| Retained profit | -38.71%1.42B | -35.76%1.43B | -16.35%1.79B | -12.82%1.7B | 23.93%2.32B | 31.76%2.22B | 33.21%2.14B | 42.14%1.96B | 31.56%1.87B | 25.61%1.69B |
| Less:Treasury stock | --321.03M | --226.99M | --39.24M | --4.25M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other composite income | -12.68%1.48M | -33.57%1.6M | 168.55%1.61M | 175.86%1.98M | 177.69%1.7M | 419.99%2.41M | 169.74%600.26K | 159.85%719.36K | 209.18%611.19K | -63.14%-753.75K |
| Shareholders equity without minority interests | -22.35%3.81B | -17.41%3.91B | -4.30%4.41B | 34.18%5.28B | 47.26%4.91B | 49.02%4.73B | 50.34%4.61B | 19.65%3.94B | 15.78%3.33B | 13.35%3.17B |
| Minority interests | 10,742.73%934.81M | 11,434.77%1.01B | 12,420.67%1.07B | 2,255.81%202.45M | 0.48%8.62M | 3.70%8.77M | 3.70%8.55M | 4.04%8.59M | -0.30%8.58M | -0.34%8.46M |
| Total shareholder equity | -3.48%4.75B | 3.80%4.92B | 18.72%5.48B | 39.02%5.48B | 47.14%4.92B | 48.90%4.74B | 50.22%4.61B | 19.61%3.94B | 15.73%3.34B | 13.31%3.18B |
| Total liabilityies and equity | 6.22%5.72B | 11.54%5.89B | 24.83%6.47B | 63.01%7.47B | 46.68%5.38B | 51.97%5.28B | 54.63%5.18B | 22.53%4.58B | 17.35%3.67B | 13.50%3.47B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
